Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Physics in Medicine and Biology
|
March 12, 2019
CT beam dosimetric characterization procedure for personalized dosimetry
S Rosendahl, L Büermann, M Borowski, et al.
Biotechnology Progress
|
March 3, 2010
Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure
Amber Haynes Fradkin, Carl S Boand, Stephen P Eisenberg, et al.
Vox Sanguinis
|
July 14, 2001
Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro
H J Nielsen, K Werther, T Mynster, et al.
The Review of Scientific Instruments
|
December 3, 2015
Determination of the separation efficiencies of a single-stage cryogenic distillation setup to remove krypton out of xenon by using a (83m)Kr tracer method
S Rosendahl, E Brown, I Cristescu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 21, 2014
PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice
Christine M Fam, Stephen P Eisenberg, Sharon J Carlson, et al.
Endocrinology
|
January 20, 2007
A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats
George N Cox, Mary S Rosendahl, Elizabeth A Chlipala, et al.
Bioconjugate Chemistry
|
January 20, 2005
A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation
Mary S Rosendahl, Daniel H Doherty, Darin J Smith, et al.
Bioconjugate Chemistry
|
September 22, 2005
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor
Daniel H Doherty, Mary S Rosendahl, Darin J Smith, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 22, 2013
Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b
Ji I Lee, Stephen P Eisenberg, Mary S Rosendahl, et al.
Bioconjugate Chemistry
|
November 21, 2007
Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic
Stacie J Bell, Christine M Fam, Elizabeth A Chlipala, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Physics in Medicine and Biology
|
March 12, 2019
CT beam dosimetric characterization procedure for personalized dosimetry
S Rosendahl, L Büermann, M Borowski, et al.
Biotechnology Progress
|
March 3, 2010
Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure
Amber Haynes Fradkin, Carl S Boand, Stephen P Eisenberg, et al.
Vox Sanguinis
|
July 14, 2001
Bacteria-induced release of white cell--and platelet-derived vascular endothelial growth factor in vitro
H J Nielsen, K Werther, T Mynster, et al.
The Review of Scientific Instruments
|
December 3, 2015
Determination of the separation efficiencies of a single-stage cryogenic distillation setup to remove krypton out of xenon by using a (83m)Kr tracer method
S Rosendahl, E Brown, I Cristescu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 21, 2014
PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice
Christine M Fam, Stephen P Eisenberg, Sharon J Carlson, et al.
Endocrinology
|
January 20, 2007
A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats
George N Cox, Mary S Rosendahl, Elizabeth A Chlipala, et al.
Bioconjugate Chemistry
|
January 20, 2005
A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation
Mary S Rosendahl, Daniel H Doherty, Darin J Smith, et al.
Bioconjugate Chemistry
|
September 22, 2005
Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor
Daniel H Doherty, Mary S Rosendahl, Darin J Smith, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 22, 2013
Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b
Ji I Lee, Stephen P Eisenberg, Mary S Rosendahl, et al.
Bioconjugate Chemistry
|
November 21, 2007
Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic
Stacie J Bell, Christine M Fam, Elizabeth A Chlipala, et al.
Page
of 5